We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Fulton Financial
FULT
$4.64B
| $9K | ﹤0.01% |
+490
| New | +$9.04K |
|
777
Moelis & Co
MC
$4.94B
| $9K | ﹤0.01% |
171
-624
| -78% | -$32K |
|
778
RadNet
RDNT
$5.69B
| $9K | ﹤0.01% |
653
-209
| -24% | -$2.28K |
|
779
The RMR Group
RMR
$332M
| $9K | ﹤0.01% |
125
| – | – |
|
|
FLOW
780
DELISTED
SPX FLOW, Inc.
FLOW
| $9K | ﹤0.01% |
186
| – | – |
|
|
ARI
781
Apollo Commercial Real Estate
ARI
$885M
| $8K | ﹤0.01% |
460
+24
| +6% | +$439 |
|
782
Marcus & Millichap
MMI
$1.19B
| $8K | ﹤0.01% |
+221
| New | +$7.21K |
|
783
Northwest Bancshares
NWBI
$2.28B
| $8K | ﹤0.01% |
+504
| New | +$8.48K |
|
784
Old National Bancorp
ONB
$10.2B
| $8K | ﹤0.01% |
479
-1,332
| -74% | -$23.4K |
|
785
Provident Financial Services
PFS
$3.19B
| $8K | ﹤0.01% |
298
| – | – |
|
786
ePlus
PLUS
$2.34B
| $8K | ﹤0.01% |
204
| – | – |
|
787
Rambus
RMBS
$11B
| $8K | ﹤0.01% |
+587
| New | +$7.86K |
|
788
Rayonier Advanced Materials
RYAM
$610M
| $8K | ﹤0.01% |
393
-1,532
| -80% | -$30K |
|
|
SEM
789
DELISTED
Select Medical
SEM
| $8K | ﹤0.01% |
+870
| New | +$8.28K |
|
790
Shutterstock
SSTK
$219M
| $8K | ﹤0.01% |
157
-188
| -54% | -$8.87K |
|
791
Synaptics
SYNA
$4.15B
| $8K | ﹤0.01% |
173
-43
| -20% | -$1.95K |
|
792
Trustmark
TRMK
$2.75B
| $8K | ﹤0.01% |
259
+106
| +69% | +$3.41K |
|
793
United Natural Foods
UNFI
$2.85B
| $8K | ﹤0.01% |
181
-623
| -77% | -$28.2K |
|
794
US Physical Therapy
USPH
$1.22B
| $8K | ﹤0.01% |
99
| – | – |
|
|
LION
795
DELISTED
Fidelity Southern Corporation
LION
| $8K | ﹤0.01% |
+363
| New | +$8.52K |
|
796
Banc of California
BANC
$2.97B
| $7K | ﹤0.01% |
367
| – | – |
|
797
CorVel
CRVL
$3.19B
| $7K | ﹤0.01% |
387
| – | – |
|
798
Daktronics
DAKT
$1.04B
| $7K | ﹤0.01% |
787
+114
| +17% | +$1.05K |
|
799
Ennis
EBF
$564M
| $7K | ﹤0.01% |
347
-440
| -56% | -$8.91K |
|
800
Enanta Pharmaceuticals
ENTA
$400M
| $7K | ﹤0.01% |
90
-617
| -87% | -$47.5K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.